Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 11,000 shares at $30.36 ($329K) on 2014-10-01, disclosed to the SEC on 2014-10-01.
Scheduled sale ($329k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 7,000 | $210K | 63.9% |
| 2 | $29.57 | 3,392 | $100K | 30.5% |
| 3 | $30.36 | 608 | $18K | 5.6% |
| Total | $29.89 avg | 11,000 | $329K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |